The Syneos Health Podcast

MOAs in ONC: The Latest and Greatest in the Oncology Pipeline

July 03, 2019 Jeffrey Stewart / Jessica Lee, PhD Episode 38
The Syneos Health Podcast
MOAs in ONC: The Latest and Greatest in the Oncology Pipeline
Chapters
The Syneos Health Podcast
MOAs in ONC: The Latest and Greatest in the Oncology Pipeline
Jul 03, 2019 Episode 38
Jeffrey Stewart / Jessica Lee, PhD

Oncology continues to be one of the hottest therapeutic areas in the biopharmaceutical industry, but one that also poses some of the greatest challenges to developers.

 Jessica Lee, Ph.D., Managing Director in the Commercial Advisory Group at Syneos Health Consulting, discusses the most recent and promising innovations in oncology therapeutics, the opportunities and challenges for combination therapies, and what could be the next great breakthrough.

Like what you’re hearing?  Be sure to rate and review us!  

We want to hear from you!  If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com

Show Notes

Oncology continues to be one of the hottest therapeutic areas in the biopharmaceutical industry, but one that also poses some of the greatest challenges to developers.

 Jessica Lee, Ph.D., Managing Director in the Commercial Advisory Group at Syneos Health Consulting, discusses the most recent and promising innovations in oncology therapeutics, the opportunities and challenges for combination therapies, and what could be the next great breakthrough.

Like what you’re hearing?  Be sure to rate and review us!  

We want to hear from you!  If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com